MPO and ischemia: Nezamoleslami et al., 2020 reported that DAP had anti-oxidative features by decreasing levels of MDA and myeloperoxidase in the kidney in experimentally induced ischemia/reperfusion injury. DAP decreased the extracellular ROS via the membrane-bound NADPH oxidase enzyme (Wozel and Blasum, 2014).